Sensorion announces a modification of the conditions for exercising the share subscription warrants issued as part of the private placement carried out in August 2023
– The maturity of the BSA subscribed by Redmile in August 2023 will be postponed to December 31, 2033, with additional pre-financing of €1.6 million for Sensorion
– Redmile’s stake in the company remains unchanged at 24.8%
Montpellier, January 24, 2024, 8 p.m. CET – Sensorion (the “Company”) (FR0012596468 – ALSEN), a pioneering biotechnology company at the clinical stage,